PPHvsGDOCETF Comparison
VanEck Pharmaceutical ETF (PPH) belongs to the Uncategorized Equities segment. Goldman Sachs Future Health Care Equity ETF (GDOC) is part of the Healthcare Technology segment. Both ETFs have the same top 1 sector exposures: Healthcare. PPH is less expensive with a Total Expense Ratio (TER) of 0.36%, versus 0.75% for GDOC. PPH is up 13.41% year-to-date (YTD) with -$316M in YTD flows. GDOC performs worse with 5.57% YTD performance, and -$2M in YTD flows. Run a side-by-side ETF comparison of PPH and GDOC below, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.
PPH vs GDOC performance and flow charts
Performance
Cumulative Flows
| 1M | 3M | YTD | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|---|---|
| Perf. | PPH GDOC | +4.67%+1.76% | +4.95%+4.97% | +13.41%+5.57% | +26.91%+9.73% | +57.53%+30.59% | +69.99%n/a |
| Flows | PPH GDOC | +$15M- | +$61M- | -$316M-$2M | -$397M-$2M | +$356M-$85M | +$450M- |
| 3M | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|
| Volatility | PPH GDOC | +19.86%+15.37% | +18.46%+15.53% | +16.43%+15.05% | +15.78%n/a |
| Max drawdown | PPH GDOC | -8.47%-7.14% | -10.78%-15.39% | -17.98%-22.18% | -20.19%n/a |
| Max drawdown duration | PPH GDOC | 59d65d | 122d221d | 434d449d | 484dn/a |
PPH | GDOC | |
Last sale 10/23/2026 at 1:30 PM | $114.93 | $37.62 |
| Previous close 10/22/2026 | $117.04 | $37.95 |
| Consolidated volume 10/22/2026 | ||
| Average volume 30 days | ||
| Average discount or premium 30 days | ||
| Average Bid/Ask spread 30 days |
Create an account to view replication metrics
PPH | GDOC | |
|---|---|---|
| Tracking error | ||
| Tracking difference | ||
| 1 year cumulative return difference | ||
| Best | ||
| Worst | ||
| Daily return difference | ||
| Average | ||
| Worst | ||
PPH | GDOC | |
|---|---|---|
| Last price | $114.93 | $37.62 |
| 1D performance | -1.80% | -0.89% |
| AuM | $1.06 B | $19.75 M |
| E/R | 0.36% | 0.75% |
PPH | GDOC | |
|---|---|---|
| Management strategy | Passive | Active |
| Provider | VanEck | Goldman Sachs |
| Benchmark | MVIS US Listed Pharmaceutical 25 Index | - |
| N° of holdings | 25 | 37 |
| Asset class | Equities | - |
| Trailing 12m distribution yield | Join | Join |
| Inception date | December 20, 2011 | November 11, 2021 |
| ESG | No | No |
Countries
Sectors
Diversification
Total weight of top 15 holdings out of 15
Total weight of top 15 holdings out of 15
